Drug Studies

We have dozens of projects underway which include all aspects of pharmacology, molecular medicine and genetics. We are consistently publishing data on new drugs each year and studying many aspects of lactation, including a new study to detect cancer antigens long before they become hazardous. We have a new study to try and determine why some women have high prolactin levels, but can't make milk. Is it an unusual prolactin molecule? For more information on that study, see our page on low milk production.

Current Drugs being studied Include:

  • Vortioxetine          ( Trintellix)
  • Brexpiprazole        (Rexulti)
  • Sitagliptin              (Januvia)
  • Lisinopril               (Carace, Lisoril, Prinil, Zestril)
  • Varneclin               (Chantix)
  • Saxagliptin            (Onglyza)
  • Zoledronic Acid     (Reclast)
  • Apremilast            (Otezla)
  • Cetirizine               (Zyrtec, Reactine)
  • Promethazine       (Phenergan)
  • Cariprazine            (Vraylar)
  • Brivaracetam        (Briviact)
  • Methsuximide       (Celontin)
  • Plecanatide           (Trulance)
  • Linaclotide            (Linzess)
  • Sodium Polystyrene (Kayexalate)
  • Lorcaserin             (BelviQ)

 

If you wish to participate in one of the drugs being studied,  please contact my Clinical Research Center staff for more information at  806-414-9742

Endocannabinoids are involved in the regulation of many biological activities. They are made naturally by cells in the human body. They have been found in breast milk although their role has not been determined. It has been suggested they may initiate infant suckling, stimulate infant appetite and a feeling of well-being. They may also play a role in infant brain development. At present, there is no information about endocannabinoids in breast milk. We are asking for breastfeeding mothers to donate milk samples for analysis.  Our goal is to determine the amount of the endocannabinoid 2-arachidonoylglycerol and other endocannabinoids in breast milk.